RAC 3.31% $1.61 race oncology ltd

Ann: Impressive 40% response in Phase II Bisantrene AML Trial, page-4

  1. 85 Posts.
    lightbulb Created with Sketch. 15
    Buckle up.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.